Addition of allopurinol to traditional Vietnamese medicine shows major improvement of 100 gout patients in a single center one-year prospective study.

IF 3.8 3区 医学 Q1 RHEUMATOLOGY
Thomas Bardin, Quang Dinh Nguyen, Valérie Bausson, Khoi Tran, Nicola Dalbeth, Chuc Tran, Dai Huynh, Quang Huy Nguyen, Minh Do, Pascal Richette, Matthieu Resche-Rigon
{"title":"Addition of allopurinol to traditional Vietnamese medicine shows major improvement of 100 gout patients in a single center one-year prospective study.","authors":"Thomas Bardin, Quang Dinh Nguyen, Valérie Bausson, Khoi Tran, Nicola Dalbeth, Chuc Tran, Dai Huynh, Quang Huy Nguyen, Minh Do, Pascal Richette, Matthieu Resche-Rigon","doi":"10.1016/j.jbspin.2025.105889","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Gout is frequently severe in Vietnam, where urate-lowering drugs (ULDs) are seldom used and many patients are treated only with traditional herbal medicine. We assessed the addition of Western medicine on severe gout in Vietnamese people.</p><p><strong>Methods: </strong>100 Vietnamese, ULD- free, crystal-proven gout patients with a GFR > 60 ml/min, were prospectively followed for 1 year after allopurinol initiation. The treatment protocol included allopurinol given according to the 2016 EULAR recommendations, flare prophylaxis with colchicine during the first months, and traditional herbal medicine. At each visit, gout flares were counted by a daily diary, digital foot photographs were taken for semi quantitative tophus scoring, serum urate (SU) was measured. Ultrasound (US) scan was performed at baseline, 6 and 12 months for double contour (DC) and index tophus measurement. Quality of life (gout impact score (GIS) and function were recorded at inclusion and after 12 months. Foot gout radiographic erosion scores were obtained at baseline, 6 and 12 months. Outcomes were compared in patients who had reached SU targets at 3 months and those who did not.</p><p><strong>Results: </strong>Patients' median age and disease duration were 47 and 8 years respectively, 91 had clinical tophi and 70 foot gouty erosions. 84 patients were seen at 6 months and 68 at 12 months. Allopurinol dosage was progressively increased to a median of 600 mg/d. Significant improvement of flare rates at M6 and M12, and of GIS and function at M12 were noted and did not associate with SU targets. Tophi (assessed by photograph and US measurements) and DC sign significantly decreased from M6 in association with achievement of < 300 μmol/l SU target. Foot erosion scores significantly decreased with no association with SU targets. Mild skin rash to allopurinol developed in 7 patients.</p><p><strong>Conclusion: </strong>This one-year open study tested a global gout care delivery model in which treat to uricemia target allopurinol, Western medicine self-treatment of flares, and patient education were added to a background of traditional herbal medicine in a Vietnamese population where gout is traditionally treated with herbal medicine. This shift in practice resulted in dramatic gout improvement.</p>","PeriodicalId":54902,"journal":{"name":"Joint Bone Spine","volume":" ","pages":"105889"},"PeriodicalIF":3.8000,"publicationDate":"2025-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Joint Bone Spine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jbspin.2025.105889","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Gout is frequently severe in Vietnam, where urate-lowering drugs (ULDs) are seldom used and many patients are treated only with traditional herbal medicine. We assessed the addition of Western medicine on severe gout in Vietnamese people.

Methods: 100 Vietnamese, ULD- free, crystal-proven gout patients with a GFR > 60 ml/min, were prospectively followed for 1 year after allopurinol initiation. The treatment protocol included allopurinol given according to the 2016 EULAR recommendations, flare prophylaxis with colchicine during the first months, and traditional herbal medicine. At each visit, gout flares were counted by a daily diary, digital foot photographs were taken for semi quantitative tophus scoring, serum urate (SU) was measured. Ultrasound (US) scan was performed at baseline, 6 and 12 months for double contour (DC) and index tophus measurement. Quality of life (gout impact score (GIS) and function were recorded at inclusion and after 12 months. Foot gout radiographic erosion scores were obtained at baseline, 6 and 12 months. Outcomes were compared in patients who had reached SU targets at 3 months and those who did not.

Results: Patients' median age and disease duration were 47 and 8 years respectively, 91 had clinical tophi and 70 foot gouty erosions. 84 patients were seen at 6 months and 68 at 12 months. Allopurinol dosage was progressively increased to a median of 600 mg/d. Significant improvement of flare rates at M6 and M12, and of GIS and function at M12 were noted and did not associate with SU targets. Tophi (assessed by photograph and US measurements) and DC sign significantly decreased from M6 in association with achievement of < 300 μmol/l SU target. Foot erosion scores significantly decreased with no association with SU targets. Mild skin rash to allopurinol developed in 7 patients.

Conclusion: This one-year open study tested a global gout care delivery model in which treat to uricemia target allopurinol, Western medicine self-treatment of flares, and patient education were added to a background of traditional herbal medicine in a Vietnamese population where gout is traditionally treated with herbal medicine. This shift in practice resulted in dramatic gout improvement.

求助全文
约1分钟内获得全文 求助全文
来源期刊
Joint Bone Spine
Joint Bone Spine 医学-风湿病学
CiteScore
4.50
自引率
11.90%
发文量
184
审稿时长
25 days
期刊介绍: Bimonthly e-only international journal, Joint Bone Spine publishes in English original research articles and all the latest advances that deal with disorders affecting the joints, bones, and spine and, more generally, the entire field of rheumatology. All submitted manuscripts to the journal are subjected to rigorous peer review by international experts: under no circumstances does the journal guarantee publication before the editorial board makes its final decision. (Surgical techniques and work focusing specifically on orthopedic surgery are not within the scope of the journal.)Joint Bone Spine is indexed in the main international databases and is accessible worldwide through the ScienceDirect and ClinicalKey platforms.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信